{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:40:29Z","timestamp":1773290429609,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372870"],"award-info":[{"award-number":["81372870"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013279","name":"National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology","doi-asserted-by":"crossref","award":["2013ZX09103003004"],"award-info":[{"award-number":["2013ZX09103003004"]}],"id":[{"id":"10.13039\/501100013279","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Grant of Administration of Traditional Chinese Medicine of Jilin Province","award":["2014-ZDR"],"award-info":[{"award-number":["2014-ZDR"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s10495-017-1416-9","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T16:10:39Z","timestamp":1504282239000},"page":"1404-1418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["20(S)-25-methoxyl-dammarane-3\u03b2, 12\u03b2, 20-triol negatively regulates activation of STAT3 and ERK pathways and exhibits anti-cancer effects in HepG2 cells"],"prefix":"10.1007","volume":"22","author":[{"given":"Hui-Han","family":"Ai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Long","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Guo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Lei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Bo","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Li","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,1]]},"reference":[{"key":"1416_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.immunol.23.021704.115806","volume":"23","author":"T Kishimoto","year":"2005","unstructured":"Kishimoto T (2005) Interleukin-6: from basic science to medicine\u201340 years in immunology. Annu Rev Immunol 23:1\u201321. doi:\n                    10.1146\/annurev.immunol.23.021704.115806","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"1416_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.critrevonc.2013.08.004","volume":"89","author":"K Middleton","year":"2014","unstructured":"Middleton K, Jones J, Lwin Z, Coward JI (2014) Interleukin-6: an angiogenic target in solid tumours. Crit Rev Oncol Hematol 89(1):129\u2013139. doi:\n                    10.1016\/j.critrevonc.2013.08.004","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"1416_CR3","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.ctrv.2012.04.007","volume":"38","author":"Y Guo","year":"2012","unstructured":"Guo Y, Xu F, Lu T, Duan Z, Zhang Z (2012) Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev 38(7):904\u2013910. doi:\n                    10.1016\/j.ctrv.2012.04.007","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"1416_CR4","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cell.2013.09.031","volume":"155","author":"G He","year":"2013","unstructured":"He G, Dhar D, Nakagawa H, Font-Burgada J, Ogata H, Jiang Y, Shalapour S, Seki E, Yost SE, Jepsen K, Frazer KA, Harismendy O, Hatziapostolou M, Iliopoulos D, Suetsugu A, Hoffman RM, Tateishi R, Koike K, Karin M (2013) Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell 155(2):384\u2013396. doi:\n                    10.1016\/j.cell.2013.09.031","journal-title":"Cell"},{"issue":"1","key":"1416_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/ijc.28337","volume":"134","author":"W Ohishi","year":"2014","unstructured":"Ohishi W, Cologne JB, Fujiwara S, Suzuki G, Hayashi T, Niwa Y, Akahoshi M, Ueda K, Tsuge M, Chayama K (2014) Serum interleukin-6 associated with hepatocellular carcinoma risk: a nested case-control study. Int J Cancer 134(1):154\u2013163. doi:\n                    10.1002\/ijc.28337","journal-title":"Int J Cancer"},{"issue":"2","key":"1416_CR6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/030089160409000207","volume":"90","author":"N Songur","year":"2004","unstructured":"Songur N, Kuru B, Kalkan F, Ozdilekcan C, Cakmak H, Hizel N (2004) Serum interleukin-6 levels correlate with malnutrition and survival in patients with advanced non-small cell lung cancer. Tumori 90(2):196\u2013200","journal-title":"Tumori"},{"issue":"5","key":"1416_CR7","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/ijc.10833","volume":"103","author":"R Salgado","year":"2003","unstructured":"Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Marck E, Huget P, Dirix LY (2003) Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer 103(5):642\u2013646. doi:\n                    10.1002\/ijc.10833","journal-title":"Int J Cancer"},{"issue":"9","key":"1416_CR8","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1002\/cncr.22999","volume":"110","author":"DS Hong","year":"2007","unstructured":"Hong DS, Angelo LS, Kurzrock R (2007) Interleukin-6 and its receptor in cancer: implications for translational therapeutics. Cancer 110(9):1911\u20131928. doi:\n                    10.1002\/cncr.22999","journal-title":"Cancer"},{"issue":"13","key":"1416_CR9","first-page":"4653","volume":"9","author":"M Trikha","year":"2003","unstructured":"Trikha M, Corringham R, Klein B, Rossi JF (2003) Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. Clin Cancer Res 9(13):4653\u20134665","journal-title":"Clin Cancer Res"},{"issue":"110\u2013111","key":"1416_CR10","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.5754\/hge10799","volume":"58","author":"XH Pang","year":"2011","unstructured":"Pang XH, Zhang JP, Zhang YJ, Yan J, Pei XQ, Zhang YQ, Li JQ, Zheng L, Chen MS (2011) Preoperative levels of serum interleukin-6 in patients with hepatocellular carcinoma. Hepatogastroenterology 58(110\u2013111):1687\u20131693. doi:\n                    10.5754\/hge10799","journal-title":"Hepatogastroenterology"},{"issue":"21","key":"1416_CR11","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1038\/sj.onc.1203551","volume":"19","author":"T Hirano","year":"2000","unstructured":"Hirano T, Ishihara K, Hibi M (2000) Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19(21):2548\u20132556. doi:\n                    10.1038\/sj.onc.1203551","journal-title":"Oncogene"},{"issue":"5332","key":"1416_CR12","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","volume":"277","author":"JJ Darnell","year":"1997","unstructured":"Darnell JJ (1997) STATs and gene regulation. Science 277(5332):1630\u20131635","journal-title":"Science"},{"issue":"2","key":"1416_CR13","doi-asserted-by":"publisher","first-page":"e23828","DOI":"10.4161\/jkst.23828","volume":"2","author":"E Bournazou","year":"2013","unstructured":"Bournazou E, Bromberg J (2013) Targeting the tumor microenvironment: JAK-STAT3 signaling. JAKSTAT 2(2):e23828. doi:\n                    10.4161\/jkst.23828","journal-title":"JAKSTAT"},{"issue":"2","key":"1416_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc1275","volume":"4","author":"H Yu","year":"2004","unstructured":"Yu H, Jove R (2004) The STATs of cancer\u2013new molecular targets come of age. Nat Rev Cancer 4(2):97\u2013105. doi:\n                    10.1038\/nrc1275","journal-title":"Nat Rev Cancer"},{"issue":"49","key":"1416_CR15","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.1038\/sj.onc.1207084","volume":"22","author":"CM Leu","year":"2003","unstructured":"Leu CM, Wong FH, Chang C, Huang SF, Hu CP (2003) Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways. Oncogene 22(49):7809\u20137818. doi:\n                    10.1038\/sj.onc.1207084","journal-title":"Oncogene"},{"key":"1416_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1600-065X.1992.tb01407.x","volume":"127","author":"S Akira","year":"1992","unstructured":"Akira S, Kishimoto T (1992) IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 127:25\u201350","journal-title":"Immunol Rev"},{"issue":"4","key":"1416_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1684\/ecn.2010.0211","volume":"21","author":"G Rodriguez-Berriguete","year":"2010","unstructured":"Rodriguez-Berriguete G, Prieto A, Fraile B, Bouraoui Y, de Bethencourt FR, Martinez-Onsurbe P, Olmedilla G, Paniagua R, Royuela M (2010) Relationship between IL-6\/ERK and NF-kappaB: a study in normal and pathological human prostate gland. Eur Cytokine Netw 21(4):241\u2013250. doi:\n                    10.1684\/ecn.2010.0211","journal-title":"Eur Cytokine Netw"},{"issue":"5","key":"1416_CR18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00280-006-0300-z","volume":"59","author":"W Wang","year":"2007","unstructured":"Wang W, Zhao Y, Rayburn ER, Hill DL, Wang H, Zhang R (2007) In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother Pharmacol 59(5):589\u2013601. doi:\n                    10.1007\/s00280-006-0300-z","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"1416_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/157340607779317508","volume":"3","author":"Y Zhao","year":"2007","unstructured":"Zhao Y, Wang W, Han L, Rayburn ER, Hill DL, Wang H, Zhang R (2007) Isolation, structural determination, and evaluation of the biological activity of 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol [20(S)-25-OCH3-PPD], a novel natural product from Panax notoginseng. Med Chem 3(1):51\u201360","journal-title":"Med Chem"},{"issue":"11","key":"1416_CR20","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/j.1440-1681.2009.05203.x","volume":"36","author":"X Bi","year":"2009","unstructured":"Bi X, Zhao Y, Fang W, Yang W (2009) Anticancer activity of Panax notoginseng extract 20(S)-25-OCH3-PPD: Targetting beta-catenin signalling. Clin Exp Pharmacol Physiol 36(11):1074\u20131078. doi:\n                    10.1111\/j.1440-1681.2009.05203.x","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"1416_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.canlet.2009.01.005","volume":"278","author":"W Wang","year":"2009","unstructured":"Wang W, Rayburn ER, Zhao Y, Wang H, Zhang R (2009) Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action. Cancer Lett 278(2):241\u2013248. doi:\n                    10.1016\/j.canlet.2009.01.005","journal-title":"Cancer Lett"},{"issue":"3","key":"1416_CR22","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.lungcan.2008.11.016","volume":"65","author":"W Wang","year":"2009","unstructured":"Wang W, Rayburn ER, Hang J, Zhao Y, Wang H, Zhang R (2009) Anti-lung cancer effects of novel ginsenoside 25-OCH(3)-PPD. Lung Cancer 65(3):306\u2013311. doi:\n                    10.1016\/j.lungcan.2008.11.016","journal-title":"Lung Cancer"},{"issue":"25","key":"1416_CR23","doi-asserted-by":"publisher","first-page":"21379","DOI":"10.18632\/oncotarget.4091","volume":"6","author":"S Voruganti","year":"2015","unstructured":"Voruganti S, Qin JJ, Sarkar S, Nag S, Walbi IA, Wang S, Zhao Y, Wang W, Zhang R (2015) Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action. Oncotarget 6(25):21379\u201321394. doi:\n                    10.18632\/oncotarget.4091","journal-title":"Oncotarget"},{"issue":"7","key":"1416_CR24","doi-asserted-by":"publisher","first-page":"e41586","DOI":"10.1371\/journal.pone.0041586","volume":"7","author":"W Wang","year":"2012","unstructured":"Wang W, Zhang X, Qin JJ, Voruganti S, Nag SA, Wang MH, Wang H, Zhang R (2012). Natural product ginsenoside 25-OCH3-PPD inhibits breast cancer growth and metastasis through down-regulating MDM2. PLoS ONE 7(7), e41586. doi:\n                    10.1371\/journal.pone.0041586","journal-title":"PLoS ONE"},{"issue":"1","key":"1416_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10529-015-1964-4","volume":"38","author":"C Zhao","year":"2016","unstructured":"Zhao C, Su G, Wang X, Zhang X, Guo S, Zhao Y (2016) Antitumor activity of ginseng sapogenins, 25-OH-PPD and 25-OCH3-PPD, on gastric cancer cells. Biotechnol Lett 38(1):43\u201350. doi:\n                    10.1007\/s10529-015-1964-4","journal-title":"Biotechnol Lett"},{"issue":"2","key":"1416_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cancergencyto.2009.09.004","volume":"196","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Bao YL, Wu Y, Yu CL, Sun Y, Li YX (2010) Identification and characterization of the human SLC5A8 gene promoter. Cancer Genet Cytogenet 196(2):124\u2013132. doi:\n                    10.1016\/j.cancergencyto.2009.09.004","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"1416_CR27","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s10495-015-1202-5","volume":"21","author":"XL Gao","year":"2016","unstructured":"Gao XL, Lin H, Zhao W, Hou YQ, Bao YL, Song ZB, Sun LG, Tian SY, Liu B, Li YX (2016) JA, a new type of polyunsaturated fatty acid isolated from Juglans mandshurica Maxim, limits the survival and induces apoptosis of heptocarcinoma cells. Apoptosis 21(3):340\u2013350. doi:\n                    10.1007\/s10495-015-1202-5","journal-title":"Apoptosis"},{"issue":"8","key":"1416_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tibs.2007.06.007","volume":"32","author":"J Han","year":"2007","unstructured":"Han J, Sun P (2007) The pathways to tumor suppression via route p38. Trends Biochem Sci 32(8):364\u2013371. doi:\n                    10.1016\/j.tibs.2007.06.007","journal-title":"Trends Biochem Sci"},{"issue":"2\u20133","key":"1416_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cbi.2011.08.010","volume":"194","author":"YL Wu","year":"2011","unstructured":"Wu YL, Wan Y, Jin XJ, OuYang BQ, Bai T, Zhao YQ, Nan JX (2011) 25-OCH3-PPD induces the apoptosis of activated t-HSC\/Cl-6 cells via c-FLIP-mediated NF-kappaB activation. Chem Biol Interact 194(2\u20133):106\u2013112. doi:\n                    10.1016\/j.cbi.2011.08.010","journal-title":"Chem Biol Interact"},{"issue":"10","key":"1416_CR30","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1111\/j.1478-3231.2008.01767.x","volume":"28","author":"J Deng","year":"2008","unstructured":"Deng J, Qian Y, Geng L, Chen J, Wang X, Xie H, Yan S, Jiang G, Zhou L, Zheng S (2008) Involvement of p38 mitogen-activated protein kinase pathway in honokiol-induced apoptosis in a human hepatoma cell line (hepG2). Liver Int 28(10):1458\u20131464. doi:\n                    10.1111\/j.1478-3231.2008.01767.x","journal-title":"Liver Int"},{"issue":"6","key":"1416_CR31","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.cellsig.2012.01.018","volume":"24","author":"JG Bode","year":"2012","unstructured":"Bode JG, Ehlting C, Haussinger D (2012) The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis. Cell Signal 24(6):1185\u20131194. doi:\n                    10.1016\/j.cellsig.2012.01.018","journal-title":"Cell Signal"},{"issue":"10","key":"1416_CR32","doi-asserted-by":"publisher","first-page":"a16295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T (2014). IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol, 6(10):a16295. doi:\n                    10.1101\/cshperspect.a016295","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"1416_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pharmthera.2013.09.004","volume":"141","author":"X Yao","year":"2014","unstructured":"Yao X, Huang J, Zhong H, Shen N, Faggioni R, Fung M, Yao Y (2014) Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther 141(2):125\u2013139. doi:\n                    10.1016\/j.pharmthera.2013.09.004","journal-title":"Pharmacol Ther"},{"key":"1416_CR34","doi-asserted-by":"publisher","first-page":"8477","DOI":"10.1038\/srep08477","volume":"5","author":"W Cao","year":"2015","unstructured":"Cao W, Liu Y, Zhang R, Zhang B, Wang T, Zhu X, Mei L, Chen H, Zhang H, Ming P, Huang L (2015) Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6\/JAK1\/STAT3 signal pathway in Gefitinib-resistant lung cancer cells. Sci Rep 5:8477. doi:\n                    10.1038\/srep08477","journal-title":"Sci Rep"},{"issue":"35","key":"1416_CR35","doi-asserted-by":"publisher","first-page":"27429","DOI":"10.1074\/jbc.M110.142752","volume":"285","author":"Y Liu","year":"2010","unstructured":"Liu Y, Li PK, Li C, Lin J (2010) Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells. J Biol Chem 285(35):27429\u201327439. doi:\n                    10.1074\/jbc.M110.142752","journal-title":"J Biol Chem"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-017-1416-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-017-1416-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-017-1416-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T06:10:26Z","timestamp":1589782226000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-017-1416-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,1]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["1416"],"URL":"https:\/\/doi.org\/10.1007\/s10495-017-1416-9","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,1]]},"assertion":[{"value":"1 September 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animal experiments were approved by the Ethics Committee of our institution and were performed in accordance with Regulations for the Administration of Affairs Concerning Experimental Animals approved by the State Council and promulgated by Decree No. 2 of the State Science and Technology Commission (1988). All applicable international, national and\/or institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}